STOCK TITAN

Amgen To Present At The 18th Annual Morgan Stanley Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Amgen will present at Morgan Stanley's 18th Annual Virtual Global Healthcare Conference on Sept. 16, 2020, at 11:45 a.m. ET. CEO Robert A. Bradway will lead the presentation, which can be accessed live via Amgen's website. A replay will be available for 90 days post-event. Amgen focuses on innovative therapeutics for serious illnesses, leveraging advanced human genetics to improve health outcomes. With a history dating back to 1980, Amgen is a leader in biotechnology.

Positive
  • None.
Negative
  • None.

THOUSAND OAKS, Calif., Sept. 11, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 18th Annual Virtual Global Healthcare Conference at 11:45 a.m. ET on Wednesday, Sept. 16, 2020. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.

About Amgen 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. 

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-18th-annual-morgan-stanley-global-healthcare-conference-301128487.html

SOURCE Amgen

FAQ

When is Amgen's presentation at the Morgan Stanley Global Healthcare Conference?

Amgen will present on Sept. 16, 2020, at 11:45 a.m. ET.

Who is presenting for Amgen at the conference?

CEO Robert A. Bradway will present for Amgen.

Where can I watch Amgen's conference presentation?

The presentation can be accessed live on Amgen's website.

How long will the replay of Amgen's presentation be available?

The replay will be available for at least 90 days following the event.

What is Amgen's focus in the biotechnology industry?

Amgen focuses on discovering and developing innovative human therapeutics for serious illnesses.

Amgen Inc

NASDAQ:AMGN

AMGN Rankings

AMGN Latest News

AMGN Stock Data

150.64B
536.44M
0.25%
81.23%
1.74%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States of America
THOUSAND OAKS